scispace - formally typeset
Y

Yifang Hu

Researcher at Walter and Eliza Hall Institute of Medical Research

Publications -  35
Citations -  25473

Yifang Hu is an academic researcher from Walter and Eliza Hall Institute of Medical Research. The author has contributed to research in topics: Haematopoiesis & Cellular differentiation. The author has an hindex of 23, co-authored 34 publications receiving 16561 citations. Previous affiliations of Yifang Hu include University of Melbourne.

Papers
More filters
Journal ArticleDOI

limma powers differential expression analyses for RNA-sequencing and microarray studies

TL;DR: The philosophy and design of the limma package is reviewed, summarizing both new and historical features, with an emphasis on recent enhancements and features that have not been previously described.
Journal ArticleDOI

ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

TL;DR: ELDA is a software application for limiting dilution analysis (LDA), with particular attention to the needs of stem cell assays, which is the first limiting dilutions analysis software to provide meaningful confidence intervals for all LDA data sets, including those with 0% or 100% responses.
Journal ArticleDOI

The Molecular Signature of Tissue Resident Memory CD8 T Cells Isolated from the Brain

TL;DR: Comparing the gene expression profiles of Trm cells isolated from the brain with those of circulating memory T cellsisolated from the spleen after an acute virus infection indicates that Trm Cells are a distinct memory T cell population disconnected from the circulatingMemory T cell pool and display a unique molecular signature that likely results in optimal survival and function within their local environment.
Journal ArticleDOI

Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells

TL;DR: It is shown that mice with loss of function mutations in PRC2 components display enhanced HSC/progenitor population activity, whereas mutations that disrupt PRC1 or pleiohomeotic repressive complex are associated with HSC or progenitor cell defects.